Search results for: 'Role of Artificial Intelligence in Drug Discovery and Development'

Artificial intelligence (AI) is rapidly reshaping the priorities and operations of Indian enterprises. This Frost & Sullivan report provides a comprehensive analysis of AI adoption and deployment, drawing on survey data from IT and business decision makers across a range of industries. The analysis examines the current state of AI implementation in...

This research service overviews the global ADC market and provides a 6-year revenue forecast from 2023 to 2028. An ADC comprises multiple components such as the antibody, conjugation chemistry, linker, and payload. Many companies are working on each component while others only develop ADCs, which makes the market highly competitive. The development...

Cybersecurity has always posed a significant threat to regular business operations. While multiple threats have always existed, over the last couple of years, geopolitical chaos has led to a marked increase in cyber threats. As part of digital transformation (DT) and business continuity efforts, enterprises allow employees and consumers remote acce...

In the big data era, the need for artificial intelligence (AI) tools and applications for intelligence uses has increased dramatically as armed forces and intelligence agencies focus on consolidated solutions to collect, process, and analyze data from seemingly endless sources. Miliary intelligence (MILINT) analytics is crucial for battlefield effi...

AI s impact on global businesses in the past decade cannot be overstated. Large-scale and real-time data analysis and highly accurate prediction capabilities of AI/machine learning (ML) algorithms are significantly improving decision making processes. Moreover, AI s ability to take over routine and low-skill tasks will help firms shift their employ...

Frost & Sullivan research found the visible market success of artificial intelligence (AI)-driven interactive virtual assistants (IVAs), such as Alexa from Amazon and the Google Assistant, has been matched by specialized IVA deployments in various vertical markets such as financial services, education, and retail. Healthcare has presented opportun...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

Edge intelligence is the combination of business intelligence and automation that can sense and synthesize massive volumes of data and make decisions close to the data collection point. Applications include collecting, analyzing, and communicating data within the specified ecosystem and making real-time decisions to achieve unprecedented levels of ...